Blueshift Asset Management, LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1727827
RED BANK, NJ
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$392,796
+$137,628 QoQ
Shares Held
4,819
+56.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#316
of 497 holders
Holding Since
Dec 2020
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Blueshift Asset Management, LLC holds $9,217,770 across 26 Biotechnology names. ARWR ranks #8 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,843 | $1,149,184 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
30,383 | $1,075,254 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
2,834 | $693,678 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,118 | $637,581 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
4,209 | $558,660 | |
| 6 | INSM |
INSMED Inc
|
4,800 | $511,776 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
8,143 | $465,942 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
4,819 | $392,796 |
All Filings in ARWR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $392,796 | 4,819 | Shares | Sole | 2026-08-14 | |
| 2021-06-30 | $255,168 | 3,081 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $564,425 | 7,356 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||